MALVERN, Pa., May 29, 2013 /PRNewswire/ -- Endo Health Solutions Inc. (Nasdaq: ENDP) today announced that Alan G. Levin, Executive Vice President & Chief Financial Officer, will be leaving the Company. Mr. Levin will continue in his current role until the fall, while a search is conducted for his successor.
The Board of Directors has formed a search committee and engaged a leading search firm to assist in an external search for a new CFO.
Rajiv De Silva, Chief Executive Officer, said, "The Board and I want to thank Alan for his dedicated service and significant contributions to building Endo into one of the leading public diversified healthcare companies. I also want to recognize Alan's contributions to the ongoing assessment of the company's strategy and operations, which I launched upon my arrival at Endo. We expect a smooth transition and are confident in the plans we are putting in place to position Endo for the future and drive shareholder value."
Alan Levin said, "Endo is a great company, and I am confident that it will do well in this next phase in its evolution. I am proud to have played a role in its growth and diversification during my tenure as Chief Financial Officer. After twenty years in corporate executive positions—the last four of which have been at Endo, I look forward to a fulfilling new chapter in my life and plan to be active in corporate board service and philanthropy, while traveling and spending more time with my family."
Endo Health Solutions Inc. (Endo) is a U.S.-based diversified healthcare company that is redefining healthcare value by finding solutions for the unmet needs of patients along care pathways for pain management, pelvic health, urology, endocrinology and oncology. Through our operating companies: AMS, Endo Pharmaceuticals, HealthTronics and Qualitest, Endo is dedicated to improving care through a combination of branded products, generics, devices, technology and services that creates value for patients, providers and payers alike. Learn more at www.endo.com.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV